中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2015年
15期
23-26
,共4页
肺癌%SOX1%甲基化%ECT2
肺癌%SOX1%甲基化%ECT2
폐암%SOX1%갑기화%ECT2
Lung cancer%SOX1%Methylation%ECT2
目的:探讨肺癌细胞中SOX1基因是否直接调控ECT2的表达。方法运用甲基化特异PCR法检测50例原发肺癌和癌旁组织中SOX1的甲基化水平。以肺癌细胞株A-1细胞为研究对象,Realtime-PCR检测ECT2表达情况。通过荧光素酶报告检查法以及染色体免疫共沉淀方法检测SOX1基因是否直接调控ECT2的表达。免疫组化检测50例肺癌组织中ECT2与SOX1表达的关系。结果原发性肺癌的甲基化异常检出率是70%(35/50)。过表达SOX1后A-1细胞中ECT2表达下降,而siRNA抑制SOX1后ECT2表达升高,荧光素酶报告检查法以及染色体免疫共沉淀方法提示SOX1可直接与ECT2启动子结合,抑制ECT2的表达。SOX1与ECT2在肺癌组织中表达负相关(r=-0.433,P=0.001)。结论肺癌细胞A-1中SOX1基因直接调控ECT2的表达。
目的:探討肺癌細胞中SOX1基因是否直接調控ECT2的錶達。方法運用甲基化特異PCR法檢測50例原髮肺癌和癌徬組織中SOX1的甲基化水平。以肺癌細胞株A-1細胞為研究對象,Realtime-PCR檢測ECT2錶達情況。通過熒光素酶報告檢查法以及染色體免疫共沉澱方法檢測SOX1基因是否直接調控ECT2的錶達。免疫組化檢測50例肺癌組織中ECT2與SOX1錶達的關繫。結果原髮性肺癌的甲基化異常檢齣率是70%(35/50)。過錶達SOX1後A-1細胞中ECT2錶達下降,而siRNA抑製SOX1後ECT2錶達升高,熒光素酶報告檢查法以及染色體免疫共沉澱方法提示SOX1可直接與ECT2啟動子結閤,抑製ECT2的錶達。SOX1與ECT2在肺癌組織中錶達負相關(r=-0.433,P=0.001)。結論肺癌細胞A-1中SOX1基因直接調控ECT2的錶達。
목적:탐토폐암세포중SOX1기인시부직접조공ECT2적표체。방법운용갑기화특이PCR법검측50례원발폐암화암방조직중SOX1적갑기화수평。이폐암세포주A-1세포위연구대상,Realtime-PCR검측ECT2표체정황。통과형광소매보고검사법이급염색체면역공침정방법검측SOX1기인시부직접조공ECT2적표체。면역조화검측50례폐암조직중ECT2여SOX1표체적관계。결과원발성폐암적갑기화이상검출솔시70%(35/50)。과표체SOX1후A-1세포중ECT2표체하강,이siRNA억제SOX1후ECT2표체승고,형광소매보고검사법이급염색체면역공침정방법제시SOX1가직접여ECT2계동자결합,억제ECT2적표체。SOX1여ECT2재폐암조직중표체부상관(r=-0.433,P=0.001)。결론폐암세포A-1중SOX1기인직접조공ECT2적표체。
Objective To test whether SOX1 is a novel transcriptional repressor for ECT2 in human lung cancer. Methods 50 primary lung cancer tissues and corresponding normal tissues were detected by Methylation-specific PCR method.The expression of ECT2 in the A-1 cell was detected by Realtime-PCR.We determined whether SOX1 may regulate the expression of ECT2 by using Chromin immunoprecipitation (ChIP) assay and Luciferase activity assay.Immunohistochemical analysis was used to test whether there is an inverse correlation between ECT2 and SOX1. Results Aberrant methylation in primary lung cancer was 70% (35/50).Ectopic expression of SOX1 in the A-1 cell repressed ECT2 expression.Conversely,siRNA silencing of the SOX1 gene increased ECT2 expression.We also show that SOX1 directly interacted with and repressed the ECT2 promoter.Moreover,the analysis of 50 primary lung cancer samples revealed an inverse correlation between ECT2 and SOX1 levels(r=-0.433,P=0.001).ConclusionSOX1 is a novel transcriptional repressor for ECT2 in human lung cancer.